Free Trial

Ligand Pharmaceuticals (LGND) Insider Trading & Ownership

→ Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad)
Free LGND Stock Alerts
$71.00
+1.11 (+1.59%)
(As of 04/24/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Ligand Pharmaceuticals (NASDAQ:LGND) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$237,520.00
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$1.48 M
Get LGND Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ligand Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LGND Insider Buying and Selling by Quarter

Ad Behind the Markets
Pentagon contract could send this $2 AI stock soaring
Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...
Get all the info here >>>

Ligand Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/5/2024Stephen L SabbaDirectorSell1,893$74.30$140,649.90  
2/28/2024Octavio EspinozaCFOSell140$88.46$12,384.40  
9/22/2023Todd C DavisCEOBuy4,000$59.38$237,520.00  
5/16/2023John W KozarichDirectorSell4,444$77.20$343,076.80  
5/10/2023Stephen L SabbaDirectorSell6,408$77.13$494,249.04  
5/8/2023John W KozarichDirectorSell6,408$76.56$490,596.48  
(Data available from 1/1/2013 forward)

LGND Insider Trading Activity - Frequently Asked Questions

Who is on Ligand Pharmaceuticals's Insider Roster?

The list of insiders at Ligand Pharmaceuticals includes Andrew Reardon, John L Higgins, John W Kozarich, Matthew W Foehr, Octavio Espinoza, Stephen L Sabba, and Todd C Davis. Learn more on insiders at LGND.

What percentage of Ligand Pharmaceuticals stock is owned by insiders?

10.40% of Ligand Pharmaceuticals stock is owned by insiders. Learn more on LGND's insider holdings.

Which Ligand Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased LGND shares in the last 24 months: Matthew W Foehr ($206,900.00), and Todd C Davis ($237,520.00).

How much insider buying is happening at Ligand Pharmaceuticals?

Insiders have purchased a total of 6,500 LGND shares in the last 24 months for a total of $444,420.00 bought.

Which Ligand Pharmaceuticals insiders have been selling company stock?

The following insiders have sold LGND shares in the last 24 months: Andrew Reardon ($20,976.00), John L Higgins ($1,581,900.00), John W Kozarich ($833,673.28), Octavio Espinoza ($140,669.84), and Stephen L Sabba ($634,898.94).

How much insider selling is happening at Ligand Pharmaceuticals?

Insiders have sold a total of 43,289 Ligand Pharmaceuticals shares in the last 24 months for a total of $3,212,118.06 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:LGND) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
The #1 Crypto for 2024
InvestorPlace
Fed launches fourth dollar overhaul
Stansberry Research
New Trump Bombshell
The Freeport Society